Overview
Ronald Scheff is an Oncologist in New York, New York. Dr. Scheff is highly rated in 15 conditions, according to our data. His top areas of expertise are Squamous Cell Lung Carcinoma, Lung Cancer, Small Cell Lung Cancer (SCLC), and Non-Small Cell Lung Cancer (NSCLC).
His clinical research consists of co-authoring 14 peer reviewed articles and participating in 6 clinical trials. MediFind looks at clinical research from the past 15 years.
Specialties
Licenses
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
Locations
520 E 70th St, New York, NY 10021
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
6 Clinical Trials
David H. Koch Center For Cancer Care At Memorial Sloan Kettering Cancer Center
Alison Moskowitz is a Hematologist and an Oncologist in New York, New York. Dr. Moskowitz is highly rated in 32 conditions, according to our data. Her top areas of expertise are T-Cell Lymphoma, Hodgkin Lymphoma, Peripheral T-Cell Lymphoma, Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Moskowitz is currently accepting new patients.
David H. Koch Center For Cancer Care At Memorial Sloan Kettering Cancer Center
Steven Horwitz is a Hematologist and an Oncologist in New York, New York. Dr. Horwitz is highly rated in 26 conditions, according to our data. His top areas of expertise are Peripheral T-Cell Lymphoma, T-Cell Lymphoma, Non-Hodgkin Lymphoma, Anaplastic Large Cell Lymphoma, and Bone Marrow Aspiration. Dr. Horwitz is currently accepting new patients.
David H. Koch Center For Cancer Care At Memorial Sloan Kettering Cancer Center
Gilles Salles is a Hematologist and an Oncologist in New York, New York. Dr. Salles is highly rated in 27 conditions, according to our data. His top areas of expertise are Non-Hodgkin Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), Follicular Lymphoma, Bone Marrow Transplant, and Splenectomy. Dr. Salles is currently accepting new patients.
Frequently Asked Questions about Dr. Ronald Scheff
How do I make an appointment with Dr. Ronald Scheff?
You can book an appointment with Dr. Ronald Scheff by calling their office at 646-962-2066. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Ronald Scheff a top-rated expert for Squamous Cell Lung Carcinoma?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Ronald Scheff is classified as an Distinguished expert for Squamous Cell Lung Carcinoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Ronald Scheff specialize in?
While Dr. Ronald Scheff is a Oncology, they have specific expertise in Squamous Cell Lung Carcinoma, Lung Cancer, and Small Cell Lung Cancer (SCLC). MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Oncology.
Does Dr. Ronald Scheff participate in research or clinical trials?
Yes. Dr. Ronald Scheff has published 14 articles and abstracts on conditions like Squamous Cell Lung Carcinoma. You can view a list of Dr. Ronald Scheff's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Ronald Scheff accept my insurance?
Dr. Ronald Scheff accepts most major insurance plans, including Cigna and Humana. We recommend calling the office directly at 646-962-2066 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- ALK-Positive Non-Small Cell Lung CancerDr. Scheff isDistinguished. Learn about ALK-Positive Non-Small Cell Lung Cancer.
- EGFR Positive Lung CancerDr. Scheff isDistinguished. Learn about EGFR Positive Lung Cancer.
- Large-Cell Lung CarcinomaDr. Scheff isDistinguished. Learn about Large-Cell Lung Carcinoma.
- Lung AdenocarcinomaDr. Scheff isDistinguished. Learn about Lung Adenocarcinoma.
- Lung CancerDr. Scheff isDistinguished. Learn about Lung Cancer.
- Non-Small Cell Lung Cancer (NSCLC)Dr. Scheff isDistinguished. Learn about Non-Small Cell Lung Cancer (NSCLC).
- Advanced
- Atypical Hemolytic Uremic Syndrome (aHUS)
- D-Plus Hemolytic Uremic SyndromeDr. Scheff isAdvanced. Learn about D-Plus Hemolytic Uremic Syndrome.
- Hemolytic-Uremic SyndromeDr. Scheff isAdvanced. Learn about Hemolytic-Uremic Syndrome.
- Metastatic Pleural TumorDr. Scheff isAdvanced. Learn about Metastatic Pleural Tumor.
- Posterior Fossa TumorDr. Scheff isAdvanced. Learn about Posterior Fossa Tumor.
- Primitive Neuroectodermal Tumor (PNET)
- Experienced
- AngiosarcomaDr. Scheff isExperienced. Learn about Angiosarcoma.
- AstrocytomaDr. Scheff isExperienced. Learn about Astrocytoma.
- Atypical Teratoid Rhabdoid Tumor (ATRT)Dr. Scheff isExperienced. Learn about Atypical Teratoid Rhabdoid Tumor (ATRT).
- Autoimmune Hemolytic AnemiaDr. Scheff isExperienced. Learn about Autoimmune Hemolytic Anemia.
- Brain TumorDr. Scheff isExperienced. Learn about Brain Tumor.
- Breast CancerDr. Scheff isExperienced. Learn about Breast Cancer.